Cross Sectional CFAR HIV/COVID-19 Study

Cross Sectional Survey Of Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (COV-2) Infection And Seroprevalence In A Cohort Of HIV-Infected Children, Youth, And Adolescents

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04514016

Enrollment

Registered

2020-08-14

Start date

2020-08-12

Completion date

2021-03-17

Last updated

2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, SARS-CoV Infection

Keywords

HIV

Brief summary

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

3 Years to 25 Years

Inclusion criteria

* Being a patient to the Pediatric or Adolescent clinic located at Batchelor Children Research Institute (BCRI) * Being diagnosed with HIV infection by the time of enrollment * At enrollment, 3 to \< 26 years

Exclusion criteria

* Patient will be excluded from the study if any of the following are identified: * Patients under legal age and in the State's custody * Participant or legal guardian unable to sign Informed Consent forms * Participant unable to complete study visits

Design outcomes

Primary

Measure	Time frame	Description
Number of participants who tested positive with SARS COV-2 Infection	month 3	SARS COV-2 Infection will be analyzed from nasopharyngeal swab samples via RT-PCR assay
Number of participants who tested positive with SARS COV-2 antibody	month 3	SARS COV-2 antibody will be analyzed from blood samples via serological assay

Countries

United States

Outcome results